Cite

HARVARD Citation

    Mark, M. et al. (2022). RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. Journal of the National Cancer Institute. pp. 635-636. [Online]. 
  
Back to record